 | Up a level |
Journal Article
Fasching, Peter A. 
ORCID: 0000-0003-4885-8471, Schmatloch, Sabine ORCID: 0000-0002-0131-7515, Hauke, Jan ORCID: 0000-0001-8236-4075, Rey, Julia ORCID: 0000-0003-1801-0429, Jackisch, Christian ORCID: 0000-0001-8537-3743, Klare, Peter ORCID: 0009-0003-1733-2634, Link, Theresa ORCID: 0000-0002-2229-7867, Hanusch, Claus ORCID: 0000-0001-6505-7196, Huober, Jens ORCID: 0000-0002-8618-1820, Stefek, Andrea ORCID: 0000-0003-3596-8188, Holtschmidt, Johannes ORCID: 0000-0002-2723-1154, Schneeweiss, Andreas ORCID: 0000-0002-2429-4512, Uleer, Christoph ORCID: 0000-0002-7937-8182, Schmitt, Wolfgang D. ORCID: 0000-0002-7870-138X, Doering, Gabriele ORCID: 0009-0006-2216-1130, Rhiem, Kerstin ORCID: 0000-0002-9669-5657, Denkert, Carsten ORCID: 0000-0002-2249-0982, Schmutzler, Rita K. ORCID: 0000-0001-8160-4348, Solbach, Christine ORCID: 0000-0001-8284-3199, Hahnen, Eric ORCID: 0000-0002-1152-8367, Hartkopf, Andreas ORCID: 0000-0003-1227-1118, Untch, Michael ORCID: 0000-0002-1233-1267, Bjelic-Radisic, Vesna ORCID: 0009-0004-2575-7891, Nekljudova, Valentina ORCID: 0000-0002-2801-7387, Blohmer, Jens-Uwe ORCID: 0000-0002-7969-250X and Loibl, Sibylle ORCID: 0000-0001-6488-4958
(2025).
Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer and HRD—Long-term Survival of the GeparOLA Study.
Clinical Cancer Research, 31 (9).
pp. 1596-1604.
AACR.
ISSN 1078-0432